This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Vericel Corporation, a manufacturer of advanced cell therapy products. The contract, valued at $56,171.00, is for the delivery of CARTILAGE supplies, specifically MACI implants, surgical implants, assembled membranes, cartilage grafts, and matrices. These specialized medical products are used to support orthopedic and reconstructive procedures for veterans and active military personnel.
The contract has an ultimate completion date of November 30, 2024 and was awarded on October 8, 2024. It was not set aside for any specific business size or socioeconomic category. Vericel Corporation has a significant history of federal contracting with the VA and the Defense Health Agency, having secured over 50 contracts valued from approximately $43,000 to $111,000 since 2015. This contract demonstrates Vericel's role as a key supplier of cutting-edge cell therapy and tissue engineering solutions to the military healthcare system.
Generated 10/9/24, 9:27 AM